glp 1 agonists vs sglt2 inhibitors Use of GLP-1 Receptor and Among Patients with Type Diabetes: A Nationwide Register-Based Cohort Study SGLT2 Inhibitors and GLP-1 Receptor

Cardiovascular Support: Regular use can reduce the risk of heart disease and other cardiovascular issues

Abbreviations AThTP adenosine triphosphotiamine BCKA branched-chain -keto acid DN double-negative DP double-positive FRAP ferric reducing antioxidant power HOCl hypochlorous acid NET neutrophil extracellular trap PABA p-aminobenzoic acid PARP poly-(ADP-ribose) polymerase PDH pyruvate dehydrogenase TEAC trolox equivalent antioxidant capacity TMP thiamine monophosphate TPK1 thiamine pyrophosphokinase-1 TPP thiamine pyrophosphate Competing Interests The authors declare that there are no competing interests associated with the manuscript

Henderson YC, Mohamed ASR, Maniakas A, Chen Y, Powell RT, Peng S, Cardenas M, Williams MD, Bell D, Zafereo ME , Wang RJ, Scherer SE, Wheeler DA, Cabanillas ME, Hofmann MC, Johnson FM, Stephan CC, Sandulache V, Lai SY

Temperature exposure Moisture contact Light exposure Repeated handling Transport conditions Lyophilised product format Lyophilised Format and Storage BPC-157 10mg is supplied in lyophilised form